קואט DVI 500

Land: Israël

Taal: Hebreeuws

Bron: Ministry of Health

Werkstoffen:

FACTOR VIII (HUMAN)

Beschikbaar vanaf:

PADAGIS ISRAEL AGENCIES LTD, ISRAEL

ATC-code:

B02BD02

farmaceutische vorm:

אבקה להכנת תמיסה לזריקה

Samenstelling:

FACTOR VIII (HUMAN) 500 IU/VIAL

Toedieningsweg:

תוך-ורידי

Prescription-type:

מרשם נדרש

Geproduceerd door:

GRIFOLS THERAPEUTICS LLC., USA

Therapeutische categorie:

COAGULATION FACTOR VIII

Therapeutisch gebied:

COAGULATION FACTOR VIII

therapeutische indicaties:

For the treatment of classical hemophilia (hemophilia A) in which there is a demonstrated deficiency of activity of the plasma clotting factor, factor VIII . Koate-DVI provides a means of temporarily replacing the missing clotting factor in order to control or prevent bleeding episodes, or in order to perform emergency and elective surgery on individuals with hemophilia.

Autorisatie datum:

2015-02-28